Oncotarget, a well-known traditional multidisciplinary journal, abides with free and open access as its core values.
It focuses on this on research topics surrounding oncology, the study that is centered around preventing diseases.
In this matter, Oncotarget serves the scientific community by remaining somewhat focused on its initial focus, oncology.
Oncotarget strongly fulfills its role to the scientific community by having the journal achieved by publishing papers online consistently.
With the renowned journal’s mission stated objective being “to ensure that scientific results are widely available”, its ultimate goal is to ensure the published studies in its journal is to be studied and thoroughly researched – especially in means in furthering research openly altogether.
The ultimate reason for this is to ensure that their oncological objective can be met: using the published studies to fight successfully against diseases before they become a significant problem. Learn more about Oncotarget at Eurekalert.org.
With its core values being democratization and a methodology to match that successfully, Oncotarget is able to competently collaborate with recognized scientific indexes.
The journal also archives various published studies to allow free and open access to every researcher to further to comprehend the studies that are being conducted. Perhaps, that study can be repeated and experimented again.
As stated before, Oncotarget’s original precise focused was oncology.
Later on,the journal had added other studies such as chromosomes, microbiology, and other forms of studies.
Oncotarget as a multidisclipary traditional journal has been active since 2010.
In that short amount of time, it is currently the world’s largest oncology peer-reviewed research publication.
More Publications in a Short Amount of Time
Currently, Oncotarget is to increase amount of the journal publishes by simply increasing how many times the readers would be able to read the publication on a weekly basis.
This doesn’t mean that readers are restricted from reading Oncotarget.
Quite the opposite, Oncotarget is to be a twice-weekly publication.
Because of this, the subscribers of the media platform are to receive new issues biweekly on Tuesday and on Friday.
The stated reason behind this increased frequency is to prevent delays in the releases of their publications.
Launching Their Series of Podcasts
With the exciting news that the journal is becoming a twice-weekly publication, Oncotarget is releasing their own series of podcasts.
“Our mission has always been to make exceptional discoveries rapidly and widely available, eliminate borders between specialties by linking different fields of biomedical science and foster applications of basic and clinical science, stated Oncotarget’s editor-in-chief.
This great new auditory avenue to allow people to discover new developments in the scientific community.
The podcast series will be available on platforms such as Stitcher, Blubrry, and Soundcloud.
Strictly Free and Open Access
Remaining true to its core value of democratization of open and free access, Oncotarget continues to move the study of oncology forward. Learn more at researchgate.net